Pilar Martinez Martinez (M.P.)

Arets, B., Mané-Damas, M., Schöttler, A. K., Sikorski, P. M., Kusner, L. L., Kaminski, H. J., Losen, M., & Martinez-Martinez, P. (2025). Refinement of the rat acetylcholine receptor-specific passive transfer myasthenia gravis model using subcutaneous injections: an update to the guidelines. Scientific Reports, 15(1), Article 33062. https://doi.org/10.1038/s41598-025-15187-2

Mané-Damas, M., Schöttler, A. K., Marcuse, F., Molenaar, P., Mohile, T., Hoeijmakers, J., Hochstenbag, M., Damoiseaux, J., Maessen, J., Abdul-Hamid, M., Zur Hausen, A., de Baets, M., Losen, M., & Martinez-Martinez, P. (2025). Myasthenia gravis with antibodies against the AChR, current knowledge on pathophysiology and an update on treatment strategies with special focus on targeting plasma cells. Autoimmunity Reviews, 24(10), Article 103875. https://doi.org/10.1016/j.autrev.2025.103875

Mane-Damas, M., Schottler, A. K., Mohile, T., Arets, B., Tuzun, E., Losen, M., & Martinez-Martinez, P. (2025). Hock immunization, a refined alternative for developing experimental autoimmune myasthenia gravis (EAMG) in mice. Scientific Reports, 15(1), Article 31893. https://doi.org/10.1038/s41598-025-12446-0

van de Burgt, N. A., Kulsvehagen, L., Mane-Damas, M., Lutz, L., Lecourt, A.-C., Monserrat, C., Vinke, A. M., Kucukali, C. I., Zong, S., Hoffmann, C., Gonzalez-Vioque, E., Arango, C., Leibold, N. K., Losen, M., Molenaar, P. C., Tuzun, E., van Beveren, N. J. M., Mane, A., Rouhl, R. P. W., ... Genetic Risk Outcome Psychosis GROUP Investigators (2025). Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms. Frontiers in Neurology, 16, Article 1593042. https://doi.org/10.3389/fneur.2025.1593042

van Kruining, D., Losen, M., Dehairs, J., Swinnen, J. V., Waelkens, E., Honing, M., & Martinez-Martinez, P. (2025). Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer's disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations. Neurobiology of Disease, 210, Article 106923. https://doi.org/10.1016/j.nbd.2025.106923

Mane-Damas, M., Saxena, A., Nogales-Gadea, G., Stevens, J., Vincken, S., van Beek, M., van den Hoogen, N. J., Joosten, E. A. J., Willcox, N., Duimel, H., Maessen, J. G., Molenaar, P. C., De Baets, M. H., Losen, M., & Martinez-Martinez, P. (2025). Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients. Frontiers in Immunology, 16, Article 1521432. https://doi.org/10.3389/fimmu.2025.1521432

Vermeulen, I., Vandenbosch, M., Viot, D., Mercier, J., Cabañas, D. A.-W., Martinez-Martinez, P., Barton, P., Heeren, R. M. A., & Cillero-Pastor, B. (2025). Spatial Distribution of Brain PET Tracers by MALDI Imaging. Journal of the American Society for Mass Spectrometry, 36(4), 688-698. https://doi.org/10.1021/jasms.4c00307

Crivelli, S. M., Quadri, Z., Elsherbini, A., Vekaria, H. J., Sullivan, P. G., Zhi, W., Martinez-Martinez, P., Spassieva, S. D., & Bieberich, E. (2024). Abnormal Regulation of Mitochondrial Sphingolipids during Aging and Alzheimer's Disease. ASN Neuro, 16(1), Article 2404367. https://doi.org/10.1080/17590914.2024.2404367

Li, D., Zong, S., Yao, Y., Molenaar, P. C., Damoiseaux, J. G. M. C., Li, H., Rouhl, R. P. W., & Martinez-Martinez, P. (2024). Anti-GABAB receptor encephalitis: clinical and laboratory characteristics, imaging, treatments and prognosis. Frontiers in Immunology, 15, Article 1442733. https://doi.org/10.3389/fimmu.2024.1442733

den Hoedt, S., Crivelli, S. M., Dorst-Lagerwerf, K. Y., Leijten, F. P. J., Losen, M., de Vries, H. E., Sijbrands, E. J. G., Verhoeven, A. J. M., Martinez-Martinez, P., & Mulder, M. T. (2024). The effects of APOE4 and familial Alzheimer's disease mutations on free fatty acid profiles in mouse brain are age- and sex-dependent. Journal of Neurochemistry, 168(9), 3063-3075. https://doi.org/10.1111/jnc.16176